| 注册
首页|期刊导航|四川医学|对Ⅰb2~Ⅱb期宫颈癌术前新辅助化疗近期临床疗效观察

对Ⅰb2~Ⅱb期宫颈癌术前新辅助化疗近期临床疗效观察

张玲 唐乾坤

四川医学2012,Vol.33Issue(2):286-288,3.
四川医学2012,Vol.33Issue(2):286-288,3.

对Ⅰb2~Ⅱb期宫颈癌术前新辅助化疗近期临床疗效观察

The role of neoadjuvant chemotherapy for cervical cancer stage Ⅰb2 ~ Ⅱb

张玲 1唐乾坤1

作者信息

  • 1. 广元市第一人民医院妇产科,四川广元628017
  • 折叠

摘要

Abstract

Objective To evaluate the effectiveness of neoadjuvant chemotherapy for the treatment of cervical cancer stage Ⅰb2 ~Ⅱb. Methods The data of 89 cases of cervical cancer who received surgery during July of 2007 and June of 2011 were analyzed retrospectively. These patients were divided into two groups, 62 cases received both neoadjuvant chemotherapy and surgery and another 27 cases received only surgery. The clinical and pathology factors were compared between these two groups before and after neoadjuvant chemotherapy and surgery. Results There were 11 cases (17.7% ) had CR, 41 cases (66. 1% ) had PR, 9 cases stable in neoadjuvant chemotherapy group, 1 case had progress. The effective rate was 83. 8%. The neoadjuvant chemotherapy group had less bleeding and positive nodes compared with surgery group(P<0.05). Conclusion Neoadjuvant chemotherapy for stage Ⅰb2 ~Ⅱb cervical cancer can decrease the tumor volume, soften the parametrium and decrease the nodes metastasis.

关键词

宫颈癌/新辅助化疗/宫颈癌根治术

Key words

cervical cancer/the effectiveness of neoadjuvant chemotherapy/analyzed retrospectively

分类

医药卫生

引用本文复制引用

张玲,唐乾坤..对Ⅰb2~Ⅱb期宫颈癌术前新辅助化疗近期临床疗效观察[J].四川医学,2012,33(2):286-288,3.

四川医学

OACSTPCD

1004-0501

访问量5
|
下载量0
段落导航相关论文